Comparing multi-use syringeless and conventional single-use dual-syringe injectors in contrast-enhanced CT: efficiency, cost, and technologist satisfaction
摘要
To compare the operational efficiency, including performance, contrast media (CM) utilization, and technologist satisfaction between a multi-use syringeless power injector (MU-SPI) and a conventional single-use dual-syringe power injector (SU-DSPI).
Materials and methodsIn this IRB-approved, HIPAA-compliant retrospective study, we prospectively recorded randomly selected cases from the first week of the caseload to document equipment setup/release times, including 22 patients (mean age 59) using MU-SPI and 30 patients (mean age 60) using SU-DSPI. In addition, the quality of contrast enhancement was evaluated using 51 randomly selected paired cases where subjects had the same CT study performed with both MU-SPI and SU-DSPI. Finally, we retrospectively recorded unavoidable CM wastage in 688 SU-DSPI cases (one missing). Overall, the healthcare system recorded 9304 cases (mean age, 52 years ± 15; 4532 men) using MU-SPI and 689 cases (mean age, 53 years ± 16; 354 men) using SU-DSPI in the study period from July 2021 to March 2022. Statistical analyses were performed using t-tests, Fisher’s exact test, the Wilcoxon signed-rank test, and multivariate linear regression models.
ResultsMean injector preparation time per examination was significantly lower for MU-SPI [51.0 (SD: 26.5) seconds] versus SU-DSPI [198.8 (SD: 26.4) seconds] (p < 0.001). SU-DSPI had unavoidable CM wastage of 24.6 (SD: 16.3) mL per exam. Contrast quality showed no significant differences between the groups (p > 0.5). Costs were lower with MU-SPI ($21.70 vs. $25.00). Finally, technologists rated the MU-SPI as having better performance compared to SU-DSPI (p = 0.027).
ConclusionMU-SPI significantly enhances operational efficiency and reduces costs with comparable image quality, improving technologist satisfaction.
Key Points